# Yum China Holdings, Inc.: financial statements, quarterly

YUMC · NYSE · CIK 1673358 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/yumc.md) · [Financials](/companies/yumc/financials.md) · [Filings](/companies/yumc/filings.md) · [Insiders](/companies/yumc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/yumc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,914](/filings/0000950170-24-123668.md) | [2,493 d](/filings/0001193125-26-082824.md) | [2,958](/filings/0000950170-25-067472.md) | [2,679](/filings/0000950170-25-106199.md) | [3,071](/filings/0001193125-25-273109.md) | [2,595 d](/filings/0001193125-26-082824.md) | [2,981](/filings/0001193125-26-213131.md) | [2,787](/filings/0001193125-26-341077.md) | [3,206](/filings/0001193125-25-273109.md) | [2,823 d](/filings/0001193125-26-082824.md) | [3,271](/filings/0001193125-26-213131.md) | [3,138](/filings/0001193125-26-341077.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [323](/filings/0000950170-24-123668.md) | [110 d](/filings/0001193125-26-082824.md) | [374](/filings/0000950170-25-067472.md) | [266](/filings/0000950170-25-106199.md) | [371](/filings/0001193125-25-273109.md) | [151 d](/filings/0001193125-26-082824.md) | [399](/filings/0001193125-26-213131.md) | [304](/filings/0001193125-26-341077.md) | [400](/filings/0001193125-25-273109.md) | [187 d](/filings/0001193125-26-082824.md) | [447](/filings/0001193125-26-213131.md) | [348](/filings/0001193125-26-341077.md) |
| Income tax | $m | [100](/filings/0000950170-24-123668.md) | [33.0 d](/filings/0001193125-26-082824.md) | [113](/filings/0000950170-25-067472.md) | [77.0](/filings/0000950170-25-106199.md) | [119](/filings/0001193125-25-273109.md) | [47.0 d](/filings/0001193125-26-082824.md) | [119](/filings/0001193125-26-213131.md) | [80.0](/filings/0001193125-26-341077.md) | [114](/filings/0001193125-25-273109.md) | [56.0 d](/filings/0001193125-26-082824.md) | [123](/filings/0001193125-26-213131.md) | [92.0](/filings/0001193125-26-341077.md) |
| Net income | $m | [244](/filings/0000950170-24-123668.md) | [97.0 d](/filings/0001193125-26-082824.md) | [287](/filings/0000950170-25-067472.md) | [212](/filings/0000950170-25-106199.md) | [297](/filings/0001193125-25-273109.md) | [115 d](/filings/0001193125-26-082824.md) | [292](/filings/0001193125-26-213131.md) | [215](/filings/0001193125-26-341077.md) | [282](/filings/0001193125-25-273109.md) | [140 d](/filings/0001193125-26-082824.md) | [309](/filings/0001193125-26-213131.md) | [244](/filings/0001193125-26-341077.md) |
| Diluted EPS | $ per share | [0.58](/filings/0000950170-24-123668.md) | not reported | [0.71](/filings/0000950170-25-067472.md) | [0.55](/filings/0000950170-25-106199.md) | [0.77](/filings/0001193125-25-273109.md) | not reported | [0.77](/filings/0001193125-26-213131.md) | [0.58](/filings/0001193125-26-341077.md) | [0.76](/filings/0001193125-25-273109.md) | not reported | [0.87](/filings/0001193125-26-213131.md) | [0.70](/filings/0001193125-26-341077.md) |
| Basic EPS | $ per share | [0.59](/filings/0000950170-24-123668.md) | not reported | [0.72](/filings/0000950170-25-067472.md) | [0.55](/filings/0000950170-25-106199.md) | [0.77](/filings/0001193125-25-273109.md) | not reported | [0.78](/filings/0001193125-26-213131.md) | [0.58](/filings/0001193125-26-341077.md) | [0.76](/filings/0001193125-25-273109.md) | not reported | [0.88](/filings/0001193125-26-213131.md) | [0.70](/filings/0001193125-26-341077.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0000950170-23-061471.md) | [1.1](/filings/0000950170-25-029134.md) | [0.9](/filings/0000950170-24-055031.md) | [1.0](/filings/0000950170-24-094324.md) | [1.2](/filings/0000950170-24-123668.md) | [0.7](/filings/0001193125-26-082824.md) | [0.8](/filings/0000950170-25-067472.md) | [0.6](/filings/0000950170-25-106199.md) | [0.6](/filings/0001193125-25-273109.md) | [0.5](/filings/0001193125-26-341077.md) | [0.5](/filings/0001193125-26-213131.md) | [0.5](/filings/0001193125-26-341077.md) |
| Current assets | $bn | [3.9](/filings/0000950170-23-061471.md) | [3.4](/filings/0000950170-25-029134.md) | [3.2](/filings/0000950170-24-055031.md) | [3.3](/filings/0000950170-24-094324.md) | [3.3](/filings/0000950170-24-123668.md) | [2.7](/filings/0001193125-26-082824.md) | [2.8](/filings/0000950170-25-067472.md) | [3.0](/filings/0000950170-25-106199.md) | [3.0](/filings/0001193125-25-273109.md) | [2.4](/filings/0001193125-26-341077.md) | [2.3](/filings/0001193125-26-213131.md) | [2.4](/filings/0001193125-26-341077.md) |
| Total assets | $bn | [12.1](/filings/0000950170-23-061471.md) | [12.0](/filings/0000950170-25-029134.md) | [11.3](/filings/0000950170-24-055031.md) | [11.6](/filings/0000950170-24-094324.md) | [11.8](/filings/0000950170-24-123668.md) | [11.1](/filings/0001193125-26-082824.md) | [11.0](/filings/0000950170-25-067472.md) | [11.0](/filings/0000950170-25-106199.md) | [11.0](/filings/0001193125-25-273109.md) | [10.8](/filings/0001193125-26-341077.md) | [10.8](/filings/0001193125-26-213131.md) | [10.9](/filings/0001193125-26-341077.md) |
| Current liabilities | $bn | [2.5](/filings/0000950170-23-061471.md) | [2.4](/filings/0000950170-25-029134.md) | [2.3](/filings/0000950170-24-055031.md) | [2.7](/filings/0000950170-24-094324.md) | [2.6](/filings/0000950170-24-123668.md) | [2.3](/filings/0001193125-26-082824.md) | [2.2](/filings/0000950170-25-067472.md) | [2.2](/filings/0000950170-25-106199.md) | [2.3](/filings/0001193125-25-273109.md) | [2.2](/filings/0001193125-26-341077.md) | [2.3](/filings/0001193125-26-213131.md) | [2.4](/filings/0001193125-26-341077.md) |
| Total liabilities | $bn | [4.8](/filings/0000950170-23-061471.md) | [4.9](/filings/0000950170-25-029134.md) | [4.7](/filings/0000950170-24-055031.md) | [5.1](/filings/0000950170-24-094324.md) | [5.1](/filings/0000950170-24-123668.md) | [4.7](/filings/0001193125-26-082824.md) | [4.6](/filings/0000950170-25-067472.md) | [4.5](/filings/0000950170-25-106199.md) | [4.6](/filings/0001193125-25-273109.md) | [4.7](/filings/0001193125-26-341077.md) | [4.7](/filings/0001193125-26-213131.md) | [4.8](/filings/0001193125-26-341077.md) |
| Short-term borrowings | $bn | [0.2](/filings/0000950170-23-061471.md) | [0.2](/filings/0000950170-25-029134.md) | [0.2](/filings/0000950170-24-055031.md) | [0.4](/filings/0000950170-24-094324.md) | [0.3](/filings/0000950170-24-123668.md) | [0.1](/filings/0001193125-26-082824.md) | [0.1](/filings/0000950170-25-067472.md) | [0.0](/filings/0000950170-25-106199.md) | [0.0](/filings/0001193125-25-273109.md) | [0.0](/filings/0001193125-26-341077.md) | [0.0](/filings/0001193125-26-213131.md) | [0.1](/filings/0001193125-26-341077.md) |
| Shareholders' equity | $bn | [6.6](/filings/0000950170-23-061471.md) | [6.4](/filings/0000950170-25-029134.md) | [5.9](/filings/0000950170-24-055031.md) | [5.8](/filings/0000950170-24-094324.md) | [6.0](/filings/0000950170-24-123668.md) | [5.7](/filings/0001193125-26-082824.md) | [5.8](/filings/0000950170-25-067472.md) | [5.8](/filings/0000950170-25-106199.md) | [5.7](/filings/0001193125-25-273109.md) | [5.4](/filings/0001193125-26-341077.md) | [5.4](/filings/0001193125-26-213131.md) | [5.4](/filings/0001193125-26-341077.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [410 d](/filings/0000950170-24-123668.md) | [139 d](/filings/0001193125-26-082824.md) | [442](/filings/0000950170-25-067472.md) | [401 d](/filings/0000950170-25-106199.md) | [409 d](/filings/0001193125-25-273109.md) | [167 d](/filings/0001193125-26-082824.md) | [452](/filings/0001193125-26-213131.md) | [412 d](/filings/0001193125-26-341077.md) | [477 d](/filings/0001193125-25-273109.md) | [125 d](/filings/0001193125-26-082824.md) | [550](/filings/0001193125-26-213131.md) | [426 d](/filings/0001193125-26-341077.md) |
| Capital expenditure | $m | [167 d](/filings/0000950170-24-123668.md) | [211 d](/filings/0001193125-26-082824.md) | [189](/filings/0000950170-25-067472.md) | [169 d](/filings/0000950170-25-106199.md) | [165 d](/filings/0001193125-25-273109.md) | [182 d](/filings/0001193125-26-082824.md) | [137](/filings/0001193125-26-213131.md) | [122 d](/filings/0001193125-26-341077.md) | [126 d](/filings/0001193125-25-273109.md) | [241 d](/filings/0001193125-26-082824.md) | [144](/filings/0001193125-26-213131.md) | [127 d](/filings/0001193125-26-341077.md) |
| Dividends paid | $m | [54.0 d](/filings/0000950170-24-123668.md) | [54.0 d](/filings/0001193125-26-082824.md) | [64.0](/filings/0000950170-25-067472.md) | [62.0 d](/filings/0000950170-25-106199.md) | [61.0 d](/filings/0001193125-25-273109.md) | [61.0 d](/filings/0001193125-26-082824.md) | [90.0](/filings/0001193125-26-213131.md) | [90.0 d](/filings/0001193125-26-341077.md) | [88.0 d](/filings/0001193125-25-273109.md) | [85.0 d](/filings/0001193125-26-082824.md) | [102](/filings/0001193125-26-213131.md) | [101 d](/filings/0001193125-26-341077.md) |
| Share repurchases | $m | [158 d](/filings/0000950170-24-123668.md) | [333 d](/filings/0001193125-26-082824.md) | [679](/filings/0000950170-25-067472.md) | [190 d](/filings/0000950170-25-106199.md) | [188 d](/filings/0001193125-25-273109.md) | [192 d](/filings/0001193125-26-082824.md) | [173](/filings/0001193125-26-213131.md) | [195 d](/filings/0001193125-26-341077.md) | [324 d](/filings/0001193125-25-273109.md) | [452 d](/filings/0001193125-26-082824.md) | [218](/filings/0001193125-26-213131.md) | [312 d](/filings/0001193125-26-341077.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [424](/filings/0000950170-23-061471.md) | [423](/filings/0000950170-24-055031.md) | [422](/filings/0000950170-24-094324.md) | [420](/filings/0000950170-24-123668.md) | [403](/filings/0000950170-25-067472.md) | [391](/filings/0000950170-25-106199.md) | [385](/filings/0001193125-25-273109.md) | [378](/filings/0001193125-26-213131.md) | [374](/filings/0001193125-26-341077.md) | [369](/filings/0001193125-25-273109.md) | [354](/filings/0001193125-26-213131.md) | [349](/filings/0001193125-26-341077.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 342,458,136 at 2026-08-04, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-341077.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.